In a recent study with the postmortem brain of COVID-19 patients, SARS-CoV-2 infection activates inflammatory signaling and oxidative stress pathways resulting in hyperphosphorylation of tau which is associated with AD. Here, MAPT is linked to Alzheimer disease.